Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 14/20 | 0.61 |
| ▸ | CCNE1 | P24864 | 13/20 | 0.61 |
| ▸ | JAK2 | O60674 | 6/20 | 0.49 |
| ▸ | JAK1 | P23458 | 6/20 | 0.49 |
| ▸ | JAK3 | P52333 | 6/20 | 0.49 |
| ▸ | GSK3B | P49841 | 8/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25781680 | 0.83 | CDK2 (0.70) | CDK2CCNE1GSK3B | |
| SCHEMBL25786525 | 0.82 | CDK2 (0.75) | CDK2CCNE1GSK3B | |
| SCHEMBL25786529 | 0.79 | CDK2 (0.50) | CDK2CCNE1GSK3B | |
| SCHEMBL25784837 | 0.76 | CDK2 (1.00) | CDK2CCNE1GSK3B | |
| SCHEMBL25786615 | 0.75 | CDK2 (0.75) | CDK2CCNE1GSK3B | |
| SCHEMBL25786614 | 0.75 | CDK2 (0.75) | CDK2CCNE1GSK3B | |
| SCHEMBL25781295 | 0.73 | CDK2 (0.71) | CDK2CCNE1GSK3B | |
| SCHEMBL25781889 | 0.72 | CDK2 (0.70) | CDK2CCNE1GSK3B | |
| SCHEMBL25781887 | 0.72 | CDK2 (0.70) | CDK2CCNE1GSK3B | |
| SCHEMBL25786531 | 0.69 | ROCK2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023168686-A1 | SUBSTITUTED CYCLOPENTANES AS CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023116884-A1 | CDK2 INHIBITORS AND USE THEREOF | QILU REGOR THERAPEUTICS INC. (CN) | 2023-06-29 | — | — | WO | disclosed |